CN Stock MarketDetailed Quotes

688443 Chongqing Genrix Biopharmaceutical

Watchlist
  • 29.74
  • -2.17-6.80%
Market Closed Jun 28 15:00 CST
10.91BMarket Cap-14270P/E (TTM)

Chongqing Genrix Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-93.67%6.33K
154.92%1.21M
-69.59%139.13K
-70.57%132.8K
1,479.93%100.01K
-98.79%475.24K
148.83%457.59K
451.26K
6.33K
3,502.98%39.19M
Operating revenue
-93.67%6.33K
154.92%1.21M
-69.59%139.13K
-70.57%132.8K
1,479.93%100.01K
-98.79%475.24K
148.83%457.59K
--451.26K
--6.33K
3,502.98%39.19M
Total operating cost
-18.53%164.59M
26.40%815.12M
25.71%576M
48.51%392.06M
143.25%202.04M
72.72%644.89M
458.21M
264M
83.06M
-3.36%373.38M
Operating cost
-97.73%2.18K
39.78%739.8K
-80.66%101.06K
-80.42%98.88K
4,298.32%95.92K
-97.27%529.27K
--522.43K
--505.01K
--2.18K
2,284.31%19.4M
Operating tax surcharges
21.76%675.29K
-10.17%2.56M
-9.62%1.68M
-13.53%1.12M
-23.73%554.6K
7.31%2.85M
--1.86M
--1.3M
--727.13K
100.74%2.65M
Operating expense
--12.4M
--10.43M
--1.74M
--299.17K
----
----
----
----
----
----
Administration expense
-39.59%27.9M
6.34%163.36M
13.51%120.97M
37.88%84.14M
267.84%46.18M
534.37%153.62M
--106.57M
--61.02M
--12.56M
-78.86%24.22M
Financial expense
-172.30%-6.31M
-47.18%17.64M
-33.92%16.31M
13.77%17.76M
21.39%8.73M
5.06%33.4M
--24.69M
--15.61M
--7.19M
-5.99%31.79M
-Interest expense (Financial expense)
-20.60%7.03M
6.84%34.99M
16.86%27.73M
20.39%18.28M
21.93%8.86M
1.01%32.75M
--23.73M
--15.19M
--7.26M
-5.79%32.42M
-Interest Income (Financial expense)
-22,497.04%-13.35M
-10,742.26%-17.46M
-10,853.62%-11.53M
-824.11%-631.72K
-58.13%-59.06K
60.41%-161.07K
---105.25K
---68.36K
---37.35K
-928.34%-406.86K
Research and development
-11.29%129.93M
36.50%620.4M
34.08%435.19M
55.55%288.65M
134.05%146.47M
53.90%454.49M
--324.57M
--185.56M
--62.58M
25.21%295.32M
Credit Impairment Loss
94.39%-316.51
----
----
94.13%-1.5K
-1,534.23%-5.64K
----
---1.04K
---25.47K
---345
200.00%33.19K
Asset Impairment Loss
90.16%-60.6K
178.40%975.29K
201.31%1.01M
1,093.27%826.31K
-1,034.18%-615.67K
-364.69%-1.24M
---1M
---83.19K
---54.28K
85.28%-267.69K
Other net revenue
Fair value change income
----
-72.80%1.94M
-70.75%1.78M
-60.91%1.56M
-53.52%898.02K
73.68%7.14M
--6.07M
--3.98M
--1.93M
1,051.23%4.11M
Invest income
--11.12K
----
----
----
----
3,324.24%719.73K
--719.73K
--719.73K
----
-92.57%21.02K
Asset deal income
----
----
----
----
----
--475.24
--475.24
----
----
----
Other revenue
25.65%874.47K
-84.25%9.68M
120.18%4.84M
3.51%1.4M
0.16%695.96K
614.97%61.44M
--2.2M
--1.35M
--694.88K
-37.76%8.59M
Operating profit
18.51%-163.76M
-39.03%-801.32M
-26.34%-568.23M
-50.68%-388.15M
-149.71%-200.96M
-79.16%-576.36M
-93.08%-449.77M
-257.6M
-80.48M
13.67%-321.7M
Add:Non operating Income
----
3,058,314.12%26K
----
----
----
-99.85%0.85
--0.85
--0.85
----
-98.73%585.28
Less:Non operating expense
44.73%6.16K
1,517.98%29.41K
438.16%9.33K
212.49%5.24K
--4.26K
-99.58%1.82K
--1.73K
--1.68K
----
14,645.43%431.28K
Total profit
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-92.73%-449.77M
-257.61M
-80.48M
13.55%-322.13M
Net profit
FPtoL-163.77M
FPtoL-801.32M
FPtoL-568.24M
FPtoL-388.15M
FPtoL-200.97M
FPtoL-576.37M
FPtoL-449.77M
-257.61M
-80.48M
FPtoL-322.13M
Net profit from continuing operation
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
---449.77M
---257.61M
---80.48M
13.55%-322.13M
Net profit of parent company owners
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-92.73%-449.77M
---257.61M
---80.48M
13.55%-322.13M
Earning per share
Basic earning per share
38.36%-0.45
-19.05%-2.5
-13.41%-1.86
-50.00%-1.41
-151.72%-0.73
-79.49%-2.1
---1.64
---0.94
---0.29
---1.17
Diluted earning per share
38.36%-0.45
-19.05%-2.5
-13.41%-1.86
-50.00%-1.41
-151.72%-0.73
-79.49%-2.1
---1.64
---0.94
---0.29
---1.17
Other composite income
Total composite income
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-449.77M
-257.61M
-80.48M
13.55%-322.13M
Total composite income of parent company owners
----
----
-26.34%-568.24M
-50.68%-388.15M
----
----
---449.77M
---257.61M
---80.48M
13.55%-322.13M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
--
--
--
--
--
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -93.67%6.33K154.92%1.21M-69.59%139.13K-70.57%132.8K1,479.93%100.01K-98.79%475.24K148.83%457.59K451.26K6.33K3,502.98%39.19M
Operating revenue -93.67%6.33K154.92%1.21M-69.59%139.13K-70.57%132.8K1,479.93%100.01K-98.79%475.24K148.83%457.59K--451.26K--6.33K3,502.98%39.19M
Total operating cost -18.53%164.59M26.40%815.12M25.71%576M48.51%392.06M143.25%202.04M72.72%644.89M458.21M264M83.06M-3.36%373.38M
Operating cost -97.73%2.18K39.78%739.8K-80.66%101.06K-80.42%98.88K4,298.32%95.92K-97.27%529.27K--522.43K--505.01K--2.18K2,284.31%19.4M
Operating tax surcharges 21.76%675.29K-10.17%2.56M-9.62%1.68M-13.53%1.12M-23.73%554.6K7.31%2.85M--1.86M--1.3M--727.13K100.74%2.65M
Operating expense --12.4M--10.43M--1.74M--299.17K------------------------
Administration expense -39.59%27.9M6.34%163.36M13.51%120.97M37.88%84.14M267.84%46.18M534.37%153.62M--106.57M--61.02M--12.56M-78.86%24.22M
Financial expense -172.30%-6.31M-47.18%17.64M-33.92%16.31M13.77%17.76M21.39%8.73M5.06%33.4M--24.69M--15.61M--7.19M-5.99%31.79M
-Interest expense (Financial expense) -20.60%7.03M6.84%34.99M16.86%27.73M20.39%18.28M21.93%8.86M1.01%32.75M--23.73M--15.19M--7.26M-5.79%32.42M
-Interest Income (Financial expense) -22,497.04%-13.35M-10,742.26%-17.46M-10,853.62%-11.53M-824.11%-631.72K-58.13%-59.06K60.41%-161.07K---105.25K---68.36K---37.35K-928.34%-406.86K
Research and development -11.29%129.93M36.50%620.4M34.08%435.19M55.55%288.65M134.05%146.47M53.90%454.49M--324.57M--185.56M--62.58M25.21%295.32M
Credit Impairment Loss 94.39%-316.51--------94.13%-1.5K-1,534.23%-5.64K-------1.04K---25.47K---345200.00%33.19K
Asset Impairment Loss 90.16%-60.6K178.40%975.29K201.31%1.01M1,093.27%826.31K-1,034.18%-615.67K-364.69%-1.24M---1M---83.19K---54.28K85.28%-267.69K
Other net revenue
Fair value change income -----72.80%1.94M-70.75%1.78M-60.91%1.56M-53.52%898.02K73.68%7.14M--6.07M--3.98M--1.93M1,051.23%4.11M
Invest income --11.12K----------------3,324.24%719.73K--719.73K--719.73K-----92.57%21.02K
Asset deal income ----------------------475.24--475.24------------
Other revenue 25.65%874.47K-84.25%9.68M120.18%4.84M3.51%1.4M0.16%695.96K614.97%61.44M--2.2M--1.35M--694.88K-37.76%8.59M
Operating profit 18.51%-163.76M-39.03%-801.32M-26.34%-568.23M-50.68%-388.15M-149.71%-200.96M-79.16%-576.36M-93.08%-449.77M-257.6M-80.48M13.67%-321.7M
Add:Non operating Income ----3,058,314.12%26K-------------99.85%0.85--0.85--0.85-----98.73%585.28
Less:Non operating expense 44.73%6.16K1,517.98%29.41K438.16%9.33K212.49%5.24K--4.26K-99.58%1.82K--1.73K--1.68K----14,645.43%431.28K
Total profit 18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-92.73%-449.77M-257.61M-80.48M13.55%-322.13M
Net profit FPtoL-163.77MFPtoL-801.32MFPtoL-568.24MFPtoL-388.15MFPtoL-200.97MFPtoL-576.37MFPtoL-449.77M-257.61M-80.48MFPtoL-322.13M
Net profit from continuing operation 18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M---449.77M---257.61M---80.48M13.55%-322.13M
Net profit of parent company owners 18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-92.73%-449.77M---257.61M---80.48M13.55%-322.13M
Earning per share
Basic earning per share 38.36%-0.45-19.05%-2.5-13.41%-1.86-50.00%-1.41-151.72%-0.73-79.49%-2.1---1.64---0.94---0.29---1.17
Diluted earning per share 38.36%-0.45-19.05%-2.5-13.41%-1.86-50.00%-1.41-151.72%-0.73-79.49%-2.1---1.64---0.94---0.29---1.17
Other composite income
Total composite income 18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-449.77M-257.61M-80.48M13.55%-322.13M
Total composite income of parent company owners ---------26.34%-568.24M-50.68%-388.15M-----------449.77M---257.61M---80.48M13.55%-322.13M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion----------------
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg